TEVA PHARMACEUTICAL INDUSTRIES LTD stock analysis

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-pot

Ticker: TEVA
Exchange: NYSE
Sector: Health Care
Industry: Pharmaceuticals

Market evidence and data freshness

The public preview recorded TEVA PHARMACEUTICAL INDUSTRIES LTD at 41.92 USD on 2026-11-05T18:30:53.000Z and marked the quote as delayed. This observation is not a trading signal.

Available price history spans 2026-05-11 through 2026-11-03 across 119 observations; the listed source is CommonQuant Parquet archive backed by Yahoo Finance delayed data. The history end date differs from the latest quote date.

What should I review before buying TEVA PHARMACEUTICAL INDUSTRIES LTD stock?

Compare valuation with reported financial performance, inspect the price history, and weigh the evidence for and against the investment case. Review the risks and assumptions before making your own decision.

Inside the full analysis

Valuation
Growth
Financial health
Ownership
Research

Sign in to open the full analysis. Paid plans use included reports first, then your weekly usage limit. Access lasts 72 hours, including revisits.